Uncategorized
AMNIOX Highlights Study Showing More Than Eighty Seven Percent of Patients With Diabetic Foot Ulcers Achieve Healing When Treated with NEOX® Wound Allograft
ATLANTA--(BUSINESS WIRE)--AMNIOX Medical, Inc., a TissueTech, Inc., company, announced the results of a retrospective clinical study of cryopreserved Umbilical Cord and Amniotic Membrane (UC/AM) tissue for chronic wound management, a review of the effectiveness of NEOX® Wound Allograft in treating patients with chronic diabetic foot ulcers. The findings were presented at Superbones Superwounds East 2016, where the study’s author, Allen Raphael, DPM, was among many top speakers on faculty at the
